Frequently Asked Questions:
In 2022, the market for ENT devices was estimated to be worth USD 16485.8 million.
The market for ENT devices is anticipated to increase at a CAGR of 5.80% from 2023 to 2030, reaching USD 25881.85 million in 2030.
Endoscopes are the most popular category of device type.
Hospitals, by the end user, are the notable segment.
During the projection period, the hearing disorders category is anticipated to exhibit the highest CAGR.
The ENT devices market was ruled by North America.
The top players include Demant A/S; Sonova; GN Store Nord A/S; Ambu A/S; Pentax Medical; Karl Storz; Olympus Corporation; Richard Wolf GmbH; Cochlear Ltd.; Starkey Laboratories, Inc.; Rion Co., Ltd.; Stryker; Smith & Nephew, and others.
Growing funding from governments, a retiring population, and an increase in the percentage of people with hearing problems are the factors influencing the expansion of the ENT devices market.
The challenges limiting the growth of the ENT Devices market are the complex regulatory environment, reimbursement challenges, and the lack of awareness.
In emerging economies, a variety of prospects for the expansion of the ENT devices market exist due to reasons such as more relaxed regulatory standards, increased urbanization, better healthcare facilities, rising disposable income, and a fast-aging geriatric population. Various market companies are concentrating on growing their market presence in developing countries in order to take advantage of the industry’s growth potential.